SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.87-0.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (10476)6/15/1999 9:24:00 PM
From: Cacaito  Read Replies (2) of 17367
 
Bpi-poloxamer-surfactant patent, probably for direct lung delivery of
bpi via aerosol/nebulizer/jet/spray/ventilator and so on, like the case for cystic fibrosis and other lung infections (all speculation, all disclaimers...this is cacaito ltd, no claims allow in Bermuda).

Did Sutro read the xoma thread?
www3.techstocks.com

Maybe you got 33 total mortality, but I got $32.

Robert S could you please update your valuation model.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext